BeStock  
股票 › 生物科技 › TRVI

特雷维治疗 TRVI

美股市值排名 #2723生物科技
$14.33 +$1.52 (+11.87%)
休市 · Nov 6, 8:10 pm ET · 最新盘后价 $14.90 +3.98%
开盘$13.04
昨收$12.81
当日区间$13.00 – $14.36
成交量2.55M
市值$2.04B
市盈率(TTM)–
股息率–

股权结构与仓位

谁在持有、谁在做空,以及大资金的流向

机构持股比例107.7%-0.58 个百分点,较上季度
持仓机构数257+3 ,较上季度
内部人近期交易38次买入 / 12次卖出净买入
空头持仓比例11.24% 占流通股回补天数 4.5 · 截至 15 Oct 2026
卖空成交量占比22.6%近5日成交量平均占比

卖空成交量占当日成交量比例

6%15%24%33%Sep '26Oct '26Nov '26

大单净流入,近20个交易日

大单买入减卖出的净额(美元)。该窗口期内:+$5.47M(10个净流入日,10个净流出日)。

按单量净流入,近20个交易日

+$4.3M超大单+$1.2M大单+$6.2M中单+$974.6K小单

超大单/大单近似机构级别交易;中单/小单近似散户级别交易。各档买入减卖出净额,按窗口期累计。

已披露的前五大股东合计持有36.4%的流通股。

最大股东

  • New Enterprise Associates, Inc.9.28%
  • FMR8.82%
  • Frazier Life Sciences Management, LP6.98%
  • BlackRock6.86%
  • Vanguard Capital Management, LLC4.47%
  • Wellington Management Group3.99%
  • Vivo Capital, LLC3.58%
  • Woodline Partners LP2.86%

按投资者类型

  • Mutual Fund52.83%
  • VC/PE Fund29.77%
  • Hedge Fund18.94%
  • Public Company4.52%
  • Private Company0.87%
  • Individual/Insider0.70%
  • Insurance Company0.33%
  • Government Pension Fund0.28%

过去6次双周报告中(31 Jul 2026至15 Oct 2026),空头持仓占流通股比例已从9.26%升至11.24%。

近期机构持仓变动

股东类型期间持股变动新持股比例
Assenagon Asset Management S.A. Mutual Fund 2026/Q3 +2,001,721 2.5%
Nuveen Asset Management LLC Insurance Company 2026/Q3 +300,439 0.2%
FMR Mutual Fund 2026/Q3 +4,525,107 8.8%
Woodline Partners LP Hedge Fund 2026/Q3 +3,080,551 2.9%
First Light Asset Management, LLC Mutual Fund 2026/Q3 +2,097,215 1.5%
Assenagon Asset Management S.A. Mutual Fund 2026/Q3 +1,525,314 1.1%
Janus Henderson Group plc Mutual Fund 2026/Q3 +1,153,846 0.8%
Barclays PLC Public Company 2026/Q3 +1,084,370 0.8%
Frontier Capital Management Mutual Fund 2026/Q3 +1,076,448 2.2%
Saturn V Capital Management LP Hedge Fund 2026/Q3 +1,052,043 0.7%
Jones Hill Capital LP Hedge Fund 2026/Q3 +969,037 0.9%
Vestal Point Capital, LP Hedge Fund 2026/Q3 +933,496 2.2%
BlackRock Mutual Fund 2026/Q3 +914,840 7.8%
Vanguard Capital Management, LLC Mutual Fund 2026/Q3 +678,536 4.5%
Wellington Management Group Mutual Fund 2026/Q3 +495,504 4.0%

按报告期列出的机构买卖动态,变动幅度从大到小排列。

内部人交易

日期内部人职位交易类型股数价格交易后持股
14 Sep 2026 Michael Heffernan Independent Director Derivative Exercise and Sale -39,473 $15.88 6,351
2 Jun 2026 Anne VanLent Independent Director Other Derivative Acquisition +35,000 $13.45 35,000
2 Jun 2026 Dominick Colangelo Independent Director Other Derivative Acquisition +35,000 $13.45 35,000
2 Jun 2026 Edward Mathers Independent Director Other Derivative Acquisition +35,000 $13.45 35,000
2 Jun 2026 David Meeker Independent Chairperson Other Derivative Acquisition +35,000 $13.45 35,000
2 Jun 2026 Michael Heffernan Independent Director Other Derivative Acquisition +35,000 $13.45 35,000
18 Feb 2026 James Cassella Chief Development Officer Other Derivative Acquisition +215,000 $10.56 215,000
18 Feb 2026 Jennifer Good Co-Founder, CEO, President, & Director Other Derivative Acquisition +675,000 $10.56 675,000
18 Feb 2026 Thomas Sciascia Co-Founder & CSO Other Derivative Acquisition +85,000 $10.56 85,000
18 Feb 2026 Christopher Galletta Controller & Chief Accounting Officer Other Derivative Acquisition +35,000 $10.56 35,000
18 Feb 2026 Farrell Simon Chief Commercial Officer Other Derivative Acquisition +160,000 $10.56 160,000
7 Jan 2026 David Hastings Chief Financial Officer & Principal Financial Officer Other Derivative Acquisition +375,000 $11.21 375,000
1 Dec 2025 Christopher Galletta Controller & Chief Accounting Officer Derivative Exercise and Retained +4,225 $0.51 26,095
6 Oct 2025 Lisa Delfini Former Chief Financial Officer Intent to Sell (Form 144) -108,650 $9.50 –
2 Oct 2025 Lisa Delfini Former Chief Financial Officer Intent to Sell (Form 144) -40,000 $9.67 –
26 Aug 2025 Lisa Delfini Former Chief Financial Officer Intent to Sell (Form 144) -312,855 $8.09 –
10 Jun 2025 Anne VanLent Independent Director Other Derivative Acquisition +45,000 $6.25 45,000
10 Jun 2025 Dominick Colangelo Independent Director Other Derivative Acquisition +45,000 $6.25 45,000
10 Jun 2025 Edward Mathers Independent Director Other Derivative Acquisition +45,000 $6.25 45,000
10 Jun 2025 David Meeker Independent Chairperson Other Derivative Acquisition +45,000 $6.25 45,000

数据来自Form 4/Form 144申报文件。负数为减持(出售、赠予或代扣税款股份),正数为增持。

空头持仓(按报告期)

报告日期空头股数占流通股比例回补天数
15 Oct 2026 16,007,187 11.2% 4.5
30 Sep 2026 14,639,150 10.3% 8.3
15 Sep 2026 12,070,625 8.5% 8.8
31 Aug 2026 12,012,371 8.4% 8.0
14 Aug 2026 12,657,630 8.9% 7.8
31 Jul 2026 13,147,012 9.3% 5.4

讨论区

暂无评论——快来第一个聊聊 TRVI。

登录后参与讨论。

Scroll to Top